Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA, WHO Biosimilar Naming Proposals Take Shape

Aug 11 2014

• By Derrick Gingery

Related Content

Sandoz’s Biosimilar Filing Is Culmination Of Paradigm Shift In FDA Drug Review

Jul 28 2014

Ado-Over: FDA Uses Prefix To Get Ahead Of Pull-Down Menu Problem

Apr 22 2013

Biosimilar Suffix Naming Idea Trips On Dispensing Problem

May 21 2012

GPhA And Actavis Divorcing: Biosimilars Behind The Rift

Mar 03 2014

Related Companies

Novartis AG

Amgen, Inc.

Allergan plc

Ipsen SA

Medicis Pharmaceutical Corporation

US WorldMeds, LLC

Teva Pharmaceutical Industries Ltd.

Sanofi

Regeneron Pharmaceuticals, Inc.

Genentech, Inc.

Additional Topics

United States Regulation BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window